PharmiWeb

Global Whole Genome Synthesis Market: Emerging Technologies, Trends, and Future Growth Insight

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...
STATOpinion

For Intellia Therapeutics, CRISPR drug’s safety concern is an existential threat

Intellia Therapeutics will find it challenging to survive now that its CRISPR gene-editing treatment has been tied to severe, ...
STAT

Intellia pauses two late-stage CRISPR gene-editing trials after emergence of safety concern

Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was ...

Global Optogenetics Equipment Market Valued at USD 400 Million in 2024, Projected to Reach USD 1.2 Billion by 2033, Growing at a 15.5% CAGR from 2026 to 2033 - Market Research ...

The Global Optogenetics Equipment Market was valued at USD 400 million in 2024 and is projected to reach USD 1.2 billion by 2033, growing at a CAGR of 15.5% from 2026 to 2033. This strong growth ...

Intellia pauses gene therapy trials after patient suffers liver injury, shares slide

Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said on Monday, ...

Revvity: Software Momentum And Screening Offset China Weakness

Discover Revvity, Inc.’s latest earnings, cloud growth, and $1B buyback. Click for my updated look at RVTY stock and why I ...